ZYME logo

Zymeworks (ZYME) Cash From Investing

Annual CFI

-$207.25 M
-$153.40 M-284.88%

December 31, 2023

Summary

Performance

1-Year Change

-284.88%

3-Year Change

-377.1%

5-Year Change

-90.06%

15-Year Change

-570.98%

ZYME Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.86%
ZYME annual cash flow from investing activities is higher than 8.86% of companies in Healthcare sector

High & Low

All-time High

$144.60 M
ZYME annual cash flow from investing activities is currently -243.33% below its historical high of $144.60 million

3-Year Low

-$207.25 M
ZYME annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ZYME previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 6, 2025
ZYME next annual earnings announcement is scheduled for Mar 6, 2025

OtherZYMEcash flowmetrics:

Annual CFF

$81.85 M
ZYME annual cash flow from financing activities is $81.85 million

Annual CFO

-$118.30 M
ZYME annual cash flow from operations is -$118.30 million

Annual FCF

-$122.38 M
ZYME annual free cash flow is -$122.38 million

Annual CAPEX

$4.08 M
ZYME annual capital expenditures is $4.08 million

Quarterly CFI

$72.26 M
+$92.23 M+461.81%

September 30, 2024

Summary

Performance

3-Month Change

+461.81%

1-Year Change

+1087.66%

3-Year Change

+70.55%

5-Year Change

+417.28%

ZYME Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.98%
ZYME quarterly cash flow from investing activities is higher than 96.98% of companies in Healthcare sector

High & Low

All-time High

$80.34 M
ZYME quarterly cash flow from investing activities is currently -10.07% below its historical high of $80.34 million

3-Year Low

-$138.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZYME previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
ZYME next earnings announcement is scheduled for Mar 6, 2025

OtherZYMEcash flowmetrics:

Quarterly CFF

-$14.98 M
ZYME quarterly cash flow from financing activities is -$14.98 million

Quarterly CFO

-$5.88 M
ZYME quarterly cash flow from operations is -$5.88 million

Quarterly FCF

-$6.88 M
ZYME quarterly free cash flow is -$6.88 million

Quarterly CAPEX

$1.00 M
ZYME quarterly capital expenditures is $1.00 million

TTM CFI

$43.63 M
+$79.28 M+222.41%

September 30, 2024

Summary

Performance

3-Month Change

+222.41%

1-Year Change

+157.15%

3-Year Change

-77.02%

5-Year Change

+270.49%

ZYME TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.29%
ZYME TTM cash flow from investing activities is higher than 88.29% of companies in Healthcare sector

High & Low

All-time High

$238.18 M
ZYME TTM cash flow from investing activities is currently -81.68% below its historical high of $238.18 million

3-Year Low

-$251.39 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZYME previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 6, 2025
ZYME next earnings announcement is scheduled for Mar 6, 2025

OtherZYMEcash flowmetrics:

TTM CFF

$38.80 M
ZYME TTM cash flow from financing activities is $38.80 million

TTM CFO

-$54.58 M
ZYME TTM cash flow from operations is -$54.58 million

TTM FCF

-$59.09 M
ZYME TTM free cash flow is -$59.09 million

TTM CAPEX

$4.51 M
ZYME TTM capital expenditures is $4.51 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ZYME Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-284.9%+1087.7%+157.2%
3 y3 years-377.1%+70.5%-77.0%
5 y5 years-90.1%+417.3%+270.5%

ZYME Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-243.3%at lowat high+152.3%-69.8%+117.4%
5 y5-year-243.3%at low-10.1%+135.3%-81.7%+117.3%
alltimeall time-243.3%at low-10.1%+135.3%-81.7%+117.3%

Zymeworks Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$72.26 M(-461.8%)
$43.63 M(-222.4%)
Jun 2024
-
-$19.97 M(+173.0%)
-$35.64 M(-53.3%)
Mar 2024
-
-$7.32 M(+447.2%)
-$76.35 M(-63.2%)
Dec 2023
-$207.25 M(+284.9%)
-$1.34 M(-81.0%)
-$207.25 M(-9.1%)
Sep 2023
-
-$7.02 M(-88.4%)
-$227.98 M(-9.3%)
Jun 2023
-
-$60.67 M(-56.1%)
-$251.39 M(+18.2%)
Mar 2023
-
-$138.22 M(+526.4%)
-$212.65 M(+294.9%)
Dec 2022
-$53.85 M(-137.2%)
-$22.07 M(-27.5%)
-$53.85 M(+60.1%)
Sep 2022
-
-$30.43 M(+38.8%)
-$33.64 M(-185.9%)
Jun 2022
-
-$21.93 M(-206.6%)
$39.15 M(-55.7%)
Mar 2022
-
$20.57 M(-1207.9%)
$88.32 M(-38.9%)
Dec 2021
$144.60 M(-432.9%)
-$1.86 M(-104.4%)
$144.60 M(-23.8%)
Sep 2021
-
$42.37 M(+55.5%)
$189.85 M(+2.6%)
Jun 2021
-
$27.24 M(-64.6%)
$185.07 M(-22.3%)
Mar 2021
-
$76.85 M(+77.1%)
$238.18 M(-648.3%)
Dec 2020
-$43.44 M
$43.40 M(+15.5%)
-$43.44 M(-75.2%)
Sep 2020
-
$37.59 M(-53.2%)
-$175.04 M(-25.6%)
Jun 2020
-
$80.34 M(-139.2%)
-$235.40 M(-6.7%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$204.77 M(+132.2%)
-$252.37 M(+886.1%)
Dec 2019
-$25.59 M(-76.5%)
-$88.20 M(+287.3%)
-$25.59 M(-196.2%)
Sep 2019
-
-$22.77 M(-135.9%)
$26.59 M(-26.3%)
Jun 2019
-
$63.37 M(+188.0%)
$36.06 M(-136.2%)
Mar 2019
-
$22.00 M(-161.1%)
-$99.58 M(-8.7%)
Dec 2018
-$109.05 M(+253.0%)
-$36.01 M(+170.7%)
-$109.05 M(+23.1%)
Sep 2018
-
-$13.30 M(-81.6%)
-$88.56 M(+15.5%)
Jun 2018
-
-$72.26 M(-676.5%)
-$76.65 M(+207.3%)
Mar 2018
-
$12.54 M(-180.7%)
-$24.94 M(-19.3%)
Dec 2017
-$30.89 M(+21.4%)
-$15.53 M(+1015.4%)
-$30.89 M(+70.8%)
Sep 2017
-
-$1.39 M(-93.2%)
-$18.09 M(-1.3%)
Jun 2017
-
-$20.56 M(-412.0%)
-$18.33 M(-2.8%)
Mar 2017
-
$6.59 M(-341.6%)
-$18.86 M(-25.9%)
Dec 2016
-$25.45 M(+176.6%)
-$2.73 M(+67.0%)
-$25.45 M(+12.0%)
Sep 2016
-
-$1.63 M(-92.3%)
-$22.73 M(+7.7%)
Jun 2016
-
-$21.09 M(<-9900.0%)
-$21.09 M(<-9900.0%)
Mar 2016
-
$1000.00
$1000.00
Dec 2015
-$9.20 M(+3174.4%)
-
-
Dec 2014
-$281.00 K
-
-

FAQ

  • What is Zymeworks annual cash flow from investing activities?
  • What is the all time high annual CFI for Zymeworks?
  • What is Zymeworks annual CFI year-on-year change?
  • What is Zymeworks quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Zymeworks?
  • What is Zymeworks quarterly CFI year-on-year change?
  • What is Zymeworks TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Zymeworks?
  • What is Zymeworks TTM CFI year-on-year change?

What is Zymeworks annual cash flow from investing activities?

The current annual CFI of ZYME is -$207.25 M

What is the all time high annual CFI for Zymeworks?

Zymeworks all-time high annual cash flow from investing activities is $144.60 M

What is Zymeworks annual CFI year-on-year change?

Over the past year, ZYME annual cash flow from investing activities has changed by -$153.40 M (-284.88%)

What is Zymeworks quarterly cash flow from investing activities?

The current quarterly CFI of ZYME is $72.26 M

What is the all time high quarterly CFI for Zymeworks?

Zymeworks all-time high quarterly cash flow from investing activities is $80.34 M

What is Zymeworks quarterly CFI year-on-year change?

Over the past year, ZYME quarterly cash flow from investing activities has changed by +$79.57 M (+1087.66%)

What is Zymeworks TTM cash flow from investing activities?

The current TTM CFI of ZYME is $43.63 M

What is the all time high TTM CFI for Zymeworks?

Zymeworks all-time high TTM cash flow from investing activities is $238.18 M

What is Zymeworks TTM CFI year-on-year change?

Over the past year, ZYME TTM cash flow from investing activities has changed by +$119.98 M (+157.15%)